Holen Sie sich die Stockscreener-App
2.995
0.50%
0.015
Schlusskurs vom Vortag:
$2.98
Offen:
$3.02
24-Stunden-Volumen:
136.17K
Relative Volume:
0.24
Marktkapitalisierung:
$214.84M
Einnahmen:
$405.47M
Nettoeinkommen (Verlust:
$53.66M
KGV:
4.1597
EPS:
0.72
Netto-Cashflow:
$131.28M
1W Leistung:
+6.96%
1M Leistung:
+3.28%
6M Leistung:
-4.92%
1J Leistung:
-11.13%
1-Tages-Spanne:
$2.96
$3.08
1-Wochen-Bereich:
$2.51
$3.2154
52-Wochen-Spanne:
$2.08
$4.22
Orasure Technologies Inc Stock (OSUR) Company Profile
Firmenname
Orasure Technologies Inc
Sektor
Telefon
(503) 641-6115
Adresse
220 E FIRST ST, BETHLEHEM, PA
Compare OSUR vs ISRG, BDX, ALC, RMD, MDLN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OSUR
Orasure Technologies Inc
|
2.995 | 213.77M | 405.47M | 53.66M | 131.28M | 0.72 |
|
ISRG
Intuitive Surgical Inc
|
504.75 | 176.65B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
171.24 | 49.56B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
83.73 | 40.50B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
258.47 | 37.63B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
43.31 | 36.02B | 28.43B | 1.16B | 1.26B | 1.4457 |
Orasure Technologies Inc Stock (OSUR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-01-03 | Fortgesetzt | Evercore ISI | In-line |
| 2021-09-22 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2020-08-21 | Eingeleitet | Evercore ISI | Outperform |
| 2020-08-10 | Eingeleitet | Citigroup | Buy |
| 2020-08-10 | Eingeleitet | JP Morgan | Neutral |
| 2020-08-07 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-06-25 | Eingeleitet | Lake Street | Buy |
| 2020-04-21 | Fortgesetzt | Stephens | Equal-Weight |
| 2018-10-23 | Fortgesetzt | Raymond James | Mkt Perform |
| 2018-07-16 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2017-11-02 | Herabstufung | Jefferies | Buy → Hold |
| 2017-02-09 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2016-06-13 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-11-05 | Bestätigt | Mizuho | Buy |
| 2015-05-07 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2015-01-23 | Bestätigt | Mizuho | Buy |
| 2014-06-12 | Bestätigt | Canaccord Genuity | Buy |
| 2014-06-11 | Bestätigt | Mizuho | Buy |
| 2012-12-21 | Eingeleitet | Mizuho | Buy |
| 2012-08-08 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2012-07-05 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2012-03-27 | Eingeleitet | JMP Securities | Mkt Outperform |
Alle ansehen
Orasure Technologies Inc Aktie (OSUR) Neueste Nachrichten
OraSure (OSUR) CEO gets major stock awards, shares withheld for taxes - Stock Titan
OraSure Technologies, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:OSUR) 2026-03-03 - Seeking Alpha
Healthy Trucking Association Launches Hepatitis C Initiative - Heavy Duty Trucking
OSUR Should I Buy - Intellectia AI
OraSure Technologies, Inc. (NASDAQ:OSUR) Q4 2025 Earnings Call Transcript - Insider Monkey
OraSure Technologies, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
OraSure Technologies (OSUR) Loss Worsens To US$0.27 EPS And Tests Margin Recovery Narrative - Sahm
OraSure Technologies Q4 Earnings Call Highlights - MarketBeat
OraSure Technologies Inc (OSUR) Q4 2025 Earnings Call Highlights - GuruFocus
OraSure signals revenue ramp in H2 2026 with two FDA-submitted diagnostics launches - MSN
Earnings Call Summary | OraSure Technologies(OSUR.US) Q4 2025 Earnings Conference - 富途牛牛
OraSure: Fourth Quarter Financial Results Overview - Bitget
OraSure Technologies Inc reports results for the quarter ended September 30Earnings Summary - TradingView
OraSure closes the book on 'transition year' of 2025 - WFMZ.com
OraSure Technologies (NASDAQ:OSUR) Releases Earnings Results, Misses Expectations By $0.04 EPS - MarketBeat
Earnings call transcript: OraSure Technologies Q4 2025 earnings fall short of revenue expectations - Investing.com
OraSure: Q4 Earnings Snapshot - Barchart.com
OraSure Technologies (OSUR) Stock Falls on Q4 2025 Earnings - Quiver Quantitative
OraSure Highlights 2025 Results and 2026 Growth Outlook - TipRanks
OraSure Announces Fourth Quarter 2025 Financial Results - The Manila Times
Revenue drops as OraSure (NASDAQ: OSUR) posts deeper 2025 loss - Stock Titan
Tranche Update on OraSure Technologies, Inc.'s Equity Buyback Plan announced on March 24, 2025. - marketscreener.com
OraSure Technologies Inc expected to post a loss of 20 cents a shareEarnings Preview - TradingView
OraSure Technologies (OSUR) Expected to Announce Earnings on Wednesday - MarketBeat
Aug Technicals: Can Fulgent Genetics Inc stock outperform in a bear marketQuarterly Investment Review & Free Daily Entry Point Trade Alerts - baoquankhu1.vn
OraSure’s HIV self-test receives Health Canada license By Investing.com - Investing.com Nigeria
OraSure Technologies (NASDAQ:OSUR) Stock Price Crosses Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
OraSure makes job cuts as it ‘rebalances’ for future growth - Lehigh Valley Business
How sensitive is OraSure Technologies Inc. to inflationJuly 2025 Setups & Verified Chart Pattern Signals - mfd.ru
Will OraSure Technologies Inc. stock benefit from automationJuly 2025 Final Week & Weekly High Potential Alerts - mfd.ru
Oral HIV self-test approved for sale in Canada - CBC
Oral HIV self-test can now be sold in Canada in ‘key’ move - Global News
Canada’s first oral HIV self-test has been approved for sale - The Globe and Mail
OraSure (OSUR) Gains Health Canada Approval for OraQuick HIV Sel - GuruFocus
Orasure to Launch Oraquick?? Hiv Self-Test in Canada - marketscreener.com
OraSure’s HIV self-test receives Health Canada license - Investing.com
OraSure to Launch OraQuick™ HIV Self-Test in Canada - ChartMill
At-home oral HIV self-test approved for sale in Canada - Toronto Sun
OraSure to Announce Fourth Quarter 2025 Financial Results and Host Earnings Call on February 25th - The Manila Times
OraSure Technologies, Inc. Schedules Fourth Quarter 2025 Earnings Conference Call for February 25, 2026 - Quiver Quantitative
OraSure trimming global workforce, including here in Lehigh Valley - WFMZ.com
Treasury Yields: How does OraSure Technologies Inc perform in inflationary periodsJuly 2025 Spike Watch & Smart Allocation Stock Reports - baoquankhu1.vn
OraSure Technologies (NASDAQ:OSUR) Share Price Passes Above 200 Day Moving AverageWhat's Next? - MarketBeat
OTC/DTC Infectious Disease Diagnostics Research Report 2026: Market Strategies, Trends, and Forecasts 2025-2029 - GlobeNewswire Inc.
Aug Rallies: Should I set a stop loss on PATH2025 Risk Factors & Long Hold Capital Preservation Tips - baoquankhu1.vn
Does OraSure Technologies Inc. have a sustainable dividendEarnings Growth Summary & Long-Term Capital Growth Strategies - mfd.ru
Investment Review: Can OraSure Technologies Inc maintain sales growth2025 Support & Resistance & AI Powered Market Trend Analysis - baoquankhu1.vn
Aug Ideas: Is ATHM in a bullish channelEarnings Beat & Detailed Earnings Play Alerts - baoquankhu1.vn
OraSure files for FDA review of molecular self-test & Colli-Pee device - MSN
Risk Analysis: Does OraSure Technologies Inc. have a sustainable dividend2025 Retail Activity & Consistent Income Trade Recommendations - baoquankhu1.vn
Is OraSure Technologies Inc. stock attractive for growth ETFsPortfolio Value Report & Verified Short-Term Plans - bollywoodhelpline.com
Finanzdaten der Orasure Technologies Inc-Aktie (OSUR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Orasure Technologies Inc-Aktie (OSUR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Gagliano Nancy J | Director |
Nov 28 '25 |
Buy |
2.37 |
2,100 |
4,982 |
160,254 |
1.26%
2.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):